Advertisement

Topics

SillaJen, Lee's Pharma initiatye phase 3 PHOCUS trial of Pexa─Vec in China to treat liver cancer

17:20 EDT 7 Sep 2018 | PharmaBiz

SillaJen, Inc., a clinical─stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, and Lee's Pharmaceutical Holdings Ltd., announced the first patient has been

Original Article: SillaJen, Lee's Pharma initiatye phase 3 PHOCUS trial of Pexa─Vec in China to treat liver cancer

NEXT ARTICLE

More From BioPortfolio on "SillaJen, Lee's Pharma initiatye phase 3 PHOCUS trial of Pexa─Vec in China to treat liver cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...